BamSEC and AlphaSense Join Forces
Learn More

Entero Therapeutics Inc.

NASDAQ: ENTO    
Share price (1/8/25): $0.62    
Market cap (1/8/25): $2.947 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant Entero Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 14 pages Common Stock Purchase Warrant First Wave Biopharma, Inc
12/34/56
EX-4.1
from 8-K 15 pages Pre-Funded Common Stock Purchase Warrant First Wave Biopharma, Inc
12/34/56
EX-4.31
from 10-K 6 pages Description of Capital Stock
12/34/56
EX-4.1
from DEFA14A 10 pages Form of Warrant
12/34/56
EX-4.1
from 8-K 10 pages Form of Warrant
12/34/56
EX-4.2
from 8-K 15 pages Common Stock Purchase Warrant First Wave Biopharma, Inc
12/34/56
EX-4.1
from 8-K 15 pages Pre-Funded Common Stock Purchase Warrant First Wave Biopharma, Inc
12/34/56
EX-4.1
from 8-K 16 pages Common Stock Purchase Warrant First Wave Biopharma, Inc
12/34/56
EX-4.40
from S-1/A 21 pages First Wave Biopharma, Inc. and Colonial Stock Transfer Co., Inc. as Warrant Agent Warrant Agency Agreement Dated as of December [ ], 2023 Warrant Agency Agreement
12/34/56
EX-4.38
from S-1/A 21 pages First Wave Biopharma, Inc.. and Colonial Stock Transfer Co., Inc. as Warrant Agent Warrant Agency Agreement Dated as of December [__], 2023 Warrant Agency Agreement
12/34/56
EX-4.37
from S-1/A 16 pages Common Stock Purchase Warrant First Wave Biopharma, Inc
12/34/56
EX-4.36
from S-1/A 15 pages Pre-Funded Common Stock Purchase Warrant First Wave Biopharma, Inc
12/34/56
EX-4.1
from 8-K 21 pages Common Stock Purchase Warrant First Wave Biopharma, Inc
12/34/56
EX-4.2
from 8-K 20 pages Common Stock Purchase Warrant First Wave Biopharma, Inc
12/34/56
EX-4.1
from 8-K 21 pages Pre-Funded Common Stock Purchase Warrant First Wave Biopharma, Inc
12/34/56
EX-4.36
from S-1/A 17 pages Common Stock Purchase Warrant First Wave Biopharma, Inc
12/34/56
EX-4.35
from S-1/A 18 pages Pre-Funded Common Stock Purchase Warrant First Wave Biopharma, Inc
12/34/56
EX-4.1
from 8-K 21 pages Common Stock Purchase Warrant First Wave Biopharma, Inc
12/34/56
EX-4.31
from 10-K 9 pages Description of Capital Stock
12/34/56